Tan, V.Y.J.; Hui, N.J.; Sommat, K.; Fong, T.J.; Zhang, E.Z.Y.; Fah, L.O.; Xin Ni, C.; Mei Kim, A.; Ni Gin, O.; Ming, L.C.
Prestin as an Early Biomarker of Hearing Loss in Nasopharyngeal Cancer Patients Undergoing Induction Chemoradiation. J. Otorhinolaryngol. Hear. Balance Med. 2026, 7, 14.
https://doi.org/10.3390/ohbm7010014
AMA Style
Tan VYJ, Hui NJ, Sommat K, Fong TJ, Zhang EZY, Fah LO, Xin Ni C, Mei Kim A, Ni Gin O, Ming LC.
Prestin as an Early Biomarker of Hearing Loss in Nasopharyngeal Cancer Patients Undergoing Induction Chemoradiation. Journal of Otorhinolaryngology, Hearing and Balance Medicine. 2026; 7(1):14.
https://doi.org/10.3390/ohbm7010014
Chicago/Turabian Style
Tan, Vanessa Y. J., Ng Jia Hui, Kiattisa Sommat, Thong Jiun Fong, Edward Z. Y. Zhang, Lai Oi Fah, Chia Xin Ni, Ang Mei Kim, Ong Ni Gin, and Lim Chwee Ming.
2026. "Prestin as an Early Biomarker of Hearing Loss in Nasopharyngeal Cancer Patients Undergoing Induction Chemoradiation" Journal of Otorhinolaryngology, Hearing and Balance Medicine 7, no. 1: 14.
https://doi.org/10.3390/ohbm7010014
APA Style
Tan, V. Y. J., Hui, N. J., Sommat, K., Fong, T. J., Zhang, E. Z. Y., Fah, L. O., Xin Ni, C., Mei Kim, A., Ni Gin, O., & Ming, L. C.
(2026). Prestin as an Early Biomarker of Hearing Loss in Nasopharyngeal Cancer Patients Undergoing Induction Chemoradiation. Journal of Otorhinolaryngology, Hearing and Balance Medicine, 7(1), 14.
https://doi.org/10.3390/ohbm7010014
